These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24246980)

  • 1. Defective antibacterial barrier in inflammatory bowel disease.
    Klag T; Stange EF; Wehkamp J
    Dig Dis; 2013; 31(3-4):310-6. PubMed ID: 24246980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune dysfunction in inflammatory bowel disease.
    Gersemann M; Wehkamp J; Stange EF
    J Intern Med; 2012 May; 271(5):421-8. PubMed ID: 22324936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted enteric antimicrobial activity localises to the mucus surface layer.
    Meyer-Hoffert U; Hornef MW; Henriques-Normark B; Axelsson LG; Midtvedt T; Pütsep K; Andersson M
    Gut; 2008 Jun; 57(6):764-71. PubMed ID: 18250125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commensal-innate immune miscommunication in IBD pathogenesis.
    Cario E
    Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J; Schmid M; Stange EF
    Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
    Ijssennagger N; van der Meer R; van Mil SWC
    Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptides and colitis.
    Ho S; Pothoulakis C; Koon HW
    Curr Pharm Des; 2013; 19(1):40-7. PubMed ID: 22950497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease pathogenesis: what is new?
    Scharl M; Rogler G
    Curr Opin Gastroenterol; 2012 Jul; 28(4):301-9. PubMed ID: 22573190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
    Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
    Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural immunity--first line defense. New treatment against infections and autoimmune diseases in sight].
    Bergman P; Gudmundsson GH; Agerberth B
    Lakartidningen; 2008 Aug 20-26; 105(34):2254-9. PubMed ID: 18785598
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucus layers in inflammatory bowel disease.
    Johansson ME
    Inflamm Bowel Dis; 2014 Nov; 20(11):2124-31. PubMed ID: 25025717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human defensins in gastrointestinal diseases.
    Langhorst J; Choi KE
    Expert Rev Clin Immunol; 2011 Nov; 7(6):779-87. PubMed ID: 22014019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate antimicrobial immunity in inflammatory bowel diseases.
    Beisner J; Stange EF; Wehkamp J
    Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian antimicrobial peptides: the defense role of beta-defensins.
    Sugiarto H; Yu PL
    Biochem Biophys Res Commun; 2004 Oct; 323(3):721-7. PubMed ID: 15381059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies.
    Sperandio B; Fischer N; Sansonetti PJ
    Semin Immunol; 2015 Mar; 27(2):111-8. PubMed ID: 25936225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shigella deploy multiple countermeasures against host innate immune responses.
    Ashida H; Ogawa M; Kim M; Suzuki S; Sanada T; Punginelli C; Mimuro H; Sasakawa C
    Curr Opin Microbiol; 2011 Feb; 14(1):16-23. PubMed ID: 20934372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal mucus barrier in normal and inflamed colon.
    Corazziari ES
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S54-5. PubMed ID: 19300126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.